Genovis launches GlycINATOR™ for analysis of antibody molecules
Genovis is launching GlycINATOR at the Well Characterized Biologicals conference in Washington DC on October 21. The product is the result of a collaboration between Genovis and a research group led by Mattias Collin at Lund University. GlycINATOR is a recombinant EndoS2* enzyme and the product is marketed as a single-use reagent to be used in characterization of monoclonal antibodies. Customers are mainly active in pharmaceutical and biotech companies."It has been exciting to watch this development project progress to finished product. The project involves working closely with Lund